This tracks Canada's largest medical marijuana company's stock prices.
Long RVNC if it breaks 40.06 (the historic high). Ipo-U Turn pattern. Company is developing less invasive methods for botulinum toxin application (biggest competitor is known as Botox). Currently Trading at 997M Mkt Cap.
You can thank that little price hiking hedge fund manager and people like Bill Ackman for the Healthcare/Pharmaceutical correction. Looking at the weekly using Fibs as reference points i believe healthcare over the next few months will begin to sell. I have a target of the 1.618 extension of 59.76 and a second target of 53.31. I'm using XLV to short because...
CURE should fill the GAP at 34.96$. Probably should put profit target above 35$ to counter the psychological level. AMEX:CURE
Johnson & Johnson has seen extreme price consolidation since last November. Since they are a highly diversified healthcare company, currency translations affect their bottom line quite substantially. With the recent contraction of the US Dollar, Johnson & Johnson has broken out of a prolonged trading range. If the dollar continues to contract against other foreign...
XLV could move nicely as the healthcare stocks continue to advance, watch for a breakout with volume to take the trade and stop 8% down
Investors are expecting big things in MiMedx which is why growth is not cheap. The forward P/E is 33.6, the PEG is 6.35, and the P/S is 7.26. Still, revenue growth over the last 4 years has been shocking. In 2011, revenue was $7.8 million. In 2014, revenue had grown to $118.2 million. That’s more than a +1,500% increase in revenue over the last 4 years. The...
Who knows where this stick might go, but I think it has a bright future! The stock surged when the quarter earnings were better than expected, and the revamp of the companies financial strategy is what turned the companies previous bleak outlook around. I see this stock rising to 21.17 very soon. www.marketwatch.com
Almost Family has done a 38.2% Fibonacci Retracement. Almost Family has grown EPS by +1340% quarter over quarter, and EPS forecasts for this company are rising fast. This company has had an EPS surprise for the last 8 quarters! The company has an excellent P/S of 0.8. The catalyst for growth is that Americans are living longer and that means more home health...
Resistance breakout with higher lows and higher highs recently. Company is enjoying success with expansion of its Niobe system products in France. There is a inverted head and shoulders reversal pattern. Q4 investor conference on 2/25 4:30PM EST at ir.stereotaxis.com Stereotaxis is a healthcare technology and innovation leader in the development of robotic...
See chart for target. Also, a good company that looks to do well in the future
What I am not showing here is, that the Cyclicals are losing steam, Sensitive Market is in neutral trend, Defensive has been the buyers paradise since OCT 2014. Why I think that this can be called as a Biotech Bubble is because, It has done the same exact thing Financials did in 2007. ie., Moved tooo quick tooo far. Yes Bio Tech (Healthcare) sector is a...
A cup and handle pattern can result in strong price movement. Enter a small position and scale in if volume continues to follow through.
$TKMR has had a wild ride. Currently investors are puzzled, some say boom, others call for bust. Trending both ways in our opinion.
The Healthcare Providers industry is one of the top performing industries in the strongest Sector in the S&P500, Healthcare. McKesson Corp is in a clear uptrend and has been gaining momentum as the relative performance chart indicates it has been ourperfoming the S&P more and more. The recent Bollinger Squeeze on the Weekly chart suggests there could be a...
Interesting 60 min look here for the IBB.. after a several month run up (which looks like to be in itself a larger frame corrective B wave to a multi-year run up), price completed a beautiful proportionate AB=CD. However in order for this bounce to prove it's the next impulsive leg up instead of being a countertrend to the larger frame C downward continuation, it...